Medical research and development contract DHA sbir sequential PH II proposal no. H2-0024 titled a supersaturated oxygen emulsion for the topical treatment of ocular trauma.

Ended Definitive Contract Awarded Last action

Contract number
W81XWH21C0046
Awardee
Awarding agency
Obligated
$2,241,198

Award facts

Opportunity
  • HQ003420R0DSB Solicitation number
Contract value 100% obligated
$2,241,197.90 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 6 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Longmont, CO 80503, USA
Research
SBIR Program Phase II Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 · DHA sbir phase II enhancement--expand operations management and their quality management system (QMS) $746,898
Other Administrative Action P00002 · DHA sbir sequential PH II - H2S-0024 $0
Supplemental Agreement for work within scope P00001 · Administrative MOD DHA sbir sequential PH II - H2S-0024 title- a supersaturated oxygen emulsion for the topical treatment of ocular trauma $0
Original award $1,494,300

About this award

The Defense Health Agency awarded a $2,241,197.90 Small Business Innovation Research (SBIR) Phase II contract to Coruna Medical LLC, a woman-owned small business, to develop a supersaturated oxygen emulsion for the topical treatment of ocular trauma. The work will take place in Niwot, Colorado through March 2026. This contract builds on Coruna Medical's prior SBIR Phase I feasibility research and further develops their oxygen emulsion technology for reducing tissue damage after acute eye injuries. Coruna Medical has also supported related animal research as a subcontractor on grants from the National Institutes of Health received by the Schepens Eye Research Institute.

Quick answers

Who was awarded contract W81XWH21C0046?

W81XWH21C0046 was awarded to Coruna Medical Inc. by Defense Health Agency (Department of Defense) on May 3, 2021.

How much is contract W81XWH21C0046 worth?

The government has obligated $2,241,198 on W81XWH21C0046.

Was contract W81XWH21C0046 competed?

The extent of competition for W81XWH21C0046 was full and open competition after exclusion of sources. The government received 6 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award